Oligonucleotides Containing 6-Aza-2′-deoxyuridine
FIGURE 5. Absorption spectra of 5 µM ethidium bromide at (a) pH 8.5, (b) pH 7.0. Solid line, EB; dashed line, EB with 4 µM DNA (9‚12)
5′-d(TAGG1aCAA1aACT)‚3′-d(ATCCAG1a1aATGA); dotted line, EB with DNA (9‚12) and 0.25 mM ZnCl2.
OH (7:3, 20 mL), stirred at room temperature for 1 h, and
evaporated. To this residue was added 5% aq NaHCO3. The mixture
was extracted with CH2Cl2, the extract was dried over Na2SO4
and evaporated, and the residue was applied to FC (silica gel,
column 15 × 3 cm, CH2Cl2/MeOH, 98:2). Evaporation of the main
zone afforded a colorless foam, which was recrystallized from
MeOH to give 5a as colorless crystals (0.65 g, 82%). mp ) 141
°C, UV (MeOH); 258 (15200), 260 (15000), 325 (4300). TLC (silica
gel, CH2Cl2/MeOH, 95:5): Rf 0.26. 1H NMR (DMSO-d6,
250 MHz): δ 2.15 [m, 1H, HR-C(2′)], 2.50 [m, 1H, Hâ-C(2′)],
3.48 [m, 2H, H-C(5′)], 3.74 [m, 1H, H-C(4′)], 3.78 [s, 3H, MeO],
4.30 [m, J ) 4.78, 1H, H-C(3′)], 4.70 [t, J ) 5.37, 1H, OH-
C(5′)], 5.25 (d, J ) 4.50, 1H, OH-C(3′)], 6.33 [t, J ) 5.87, 1H,
H-C(1′)], 7.18 [m, 2H, aromatic], 7.60 [m, 1H, aromatic], 7.84
[s, 1H, H-C(5)], 8.01 [m, 1H, aromatic]. Anal. calcd for C16H17N3O7
(363.32): C, 52.89; H, 4.72; N, 11.57. Found: C, 52.81; H, 4.75;
N, 11.77.
base pairs are less stable than those of dT-dA. We found that
this destabilization is largely caused by the deprotonation of
the 6-aza-2′-deoxyuridine residue which takes place already
under neutral condition. A pH decrease of the buffer solution
increases the duplex stability. Oligonucleotides containing 1a
show an enhanced stability against the 3′-exonucleases (snake-
venom phosphodiesterase). The ease of deprotonation which
causes an unfavorable effect on the duplex stability results in a
very favorable behavior regarding M-DNA formation. This
metal DNA is now formed under physiological as well as
alkaline conditions unlike canonical DNA which is formed only
at alkaline pH. Because of its conductive properties M-DNA
has the capacity to act as a nanowire,25b and the use of the 6-aza-
2′-deoxyuridine in place of dT can lead its application in the
preparation of nano electronic devices being formed already
under physiological conditions.
2-(2-Deoxy-â-D-erythro-pentofuranosyl)-N4-benzoyl-1,2,4-tri-
azin-3,5(2H,4H)-dione (5b). Compound (1a) (0.2 g, 0.87 mmol)
was treated with triethylsilyl chloride (0.4 mL, 2.36 mmol) in
pyridine (2 mL) and stirred at room temperature for 1 h and then
benzoyl chloride (0.29 mL, 2.5 mmol) was added. After being
stirred for 3 h, the mixture was evaporated and coevaporated with
toluene to remove pyridine completely. The residue was further
treated with 5% CF3COOH in CH2Cl2-CH3OH (7:3, 8 mL) stirred
at room temperature for 1 h and evaporated. To this residue was
added 5% aq NaHCO3, and the mixture was extracted with CH2-
Cl2, the extract was dried over Na2SO4 and evaporated, and the
residue was applied to FC (silica gel, column 12 × 3 cm, CH2-
Cl2/MeOH, 95:5). Evaporation of the main fractions afforded 5b
as colorless foam (0.2 g, 69%). UV (MeOH); 254 (16000), 260
(14100). TLC (silica gel, CH2Cl2/MeOH 95:5): Rf 0.27. 1H NMR
(DMSO-d6, 250 MHz): δ 2.08 [m, HR-C(2′)], 2.49 [m, 1H, Hâ-
C(2′)], 3.73 [m, 2H, H-C(5′)], 4.12 [m, 1H, H-C(4′)], 4.29 [t, J
) 4.9, 1H, H-C(3′)], 4.67 [t, J ) 5.75, 1H, OH-C(5′)], 5.23 [t,
J ) 4.60, 1H, OH-C(3′)], 6.30 [t, J ) 5.70, 1H, H-C(1′)], 7.59
[m, 2H, aromatic], 7.83 [s, 1H, H-C(5)], 8.12 [m, 2H, aromatic].
Anal. Calcd for C15H15N3O6 (333.30): C, 54.05; H, 4.54; N, 12.61
Found: C, 53.99; H, 4.50; N, 12.52.
2-(2-Deoxy-â-D-erythro-pentofuranosyl)-N4-(2,4-dimethoxy-
benzoyl)-1,2,4-triazin-3,5(2H,4H)-dione (5c). Compound (1a)
(0.15 g, 0.65 mmol) was treated with triethylsilyl chloride
(0.70 mL, 4.19 mmol) in pyridine (3.0 mL) and stirred at room
temperature for 1 h, and then 2,4-dimethoxybenzoyl chloride (36
mg, 0.18 mmol) and DMAP were added. The reaction mixture was
stirred at 60 °C for overnight. The mixture was evaporated and
coevaporated with toluene to remove pyridine completely. The
residue was further treated with 5% CF3COOH in CH2Cl2-CH3-
OH (7:3, 6 mL), stirred at room temperature for 1 h, and evaporated.
To this residue was added 5% aq NaHCO3, and the mixture was
Experimental Section
M-DNA Sample Preparation. Ethidium bromide (5 µM) was
dissolved in 1 mL of buffer solution (10 mM NaCl and 10 mM
Tris-HCl, pH 8.5 or 7.0), and the UV absorbance was measured.
To this 4 µM of DNA duplex (bases) (7‚8 or 13‚14 or 9‚12) was
added, and the absorbance was read. To the same solution was
added 0.25 mM ZnCl2, and the mixture was incubated for 20 min
at rt for the formation of M-DNA followed by UV measurement.
To convert back to B-DNA, 2 mM EDTA (20 µL of 100 mM stock
solution in H2O) was added to each sample and the absorbance
was measured.
Precipitation of DNA Using Zn+2. The oligonucleotides 13 or
7‚8 (1.9 nmol) were dissolved in 1.0 mL of buffer (10 mM Tris-
HCl, 0.2 mM sodium phosphate, pH 8.5). To this solution were
added various concentrations of ZnCl2 (0-5 mM, from 50 mM
stock solution), the mixture was incubated for 20 min at room
temperature, then the samples were centrifuged at 5000 rpm for
5 min, the supernatant was carefully taken out, and the absorbance
was measured at 260 nm. Based on that, the amount of precipitated
DNA was calculated (Table 5). To recover the DNA, the above
precipitated samples were suspended in buffer (1.0 mL of 10 mM
TRIS-HCl, 1 mM EDTA, pH 8.5), and UV absorbance was
measured at 260 nm (Table 6).
2-(2-Deoxy-â-D-erythro-pentofuranosyl)-N4-(2-methoxybenzoyl)-
1,2,4-triazin-3,5(2H,4H)-dione (5a). Compound 1a16 (0.5 g,
2.18 mmol) was treated with triethylsilyl chloride (0.94 mL,
5.61 mmol) in pyridine (3.5 mL) and stirred at room temperature
for 1 h, and then o-anisoyl chloride (0.49 mL, 3.29 mmol) was
added. After being stirred for 3 h, the mixture was evaporated and
coevaporated with toluene to remove pyridine completely. The oily
residue was further treated with 5% CF3COOH in CH2Cl2-CH3-
J. Org. Chem, Vol. 72, No. 12, 2007 4365